@article{fdi:010063238,
  title = {{HIV}/{AIDS}-related mortality in {A}frica and {A}sia : evidence from {INDEPTH} health and demographic surveillance system sites},
  author = {{S}treatfield, {P}.{K}. and {K}han, {W}.{A}. and {B}huiya, {A}. and {D}elaunay, {V}al{\'e}rie and {S}okhna, {C}heikh and et al.},
  editor = {},
  language = {{ENG}},
  abstract = {{B}ackground: {A}s the {HIV}/{AIDS} pandemic has evolved over recent decades, {A}frica has been the most affected region, even though a large proportion of {HIV}/{AIDS} deaths have not been documented at the individual level. {S}ystematic application of verbal autopsy ({VA}) methods in defined populations provides an opportunity to assess the mortality burden of the pandemic from individual data. {O}bjective: {T}o present standardised comparisons of {HIV}/{AIDS}-related mortality at sites across {A}frica and {A}sia, including closely related causes of death such as pulmonary tuberculosis ({PTB}) and pneumonia. {D}esign: {D}eaths related to {HIV}/{AIDS} were extracted from individual demographic and {VA} data from 22 {INDEPTH} sites across {A}frica and {A}sia. {VA} data were standardised to {WHO} 2012 standard causes of death assigned using the {I}nter{VA}-4 model. {B}etween-site comparisons of mortality rates were standardised using the {INDEPTH} 2013 standard population. {R}esults: {T}he dataset covered a total of 10,773 deaths attributed to {HIV}/{AIDS}, observed over 12,204,043 person-years. {HIV}/{AIDS}-related mortality fractions and mortality rates varied widely across {A}frica and {A}sia, with highest burdens in eastern and southern {A}frica, and lowest burdens in {A}sia. {T}here was evidence of rapidly declining rates at the sites with the heaviest burdens. {HIV}/{AIDS} mortality was also strongly related to {PTB} mortality. {O}n a country basis, there were strong similarities between {HIV}/{AIDS} mortality rates at {INDEPTH} sites and those derived from modelled estimates. {C}onclusions: {M}easuring {HIV}/{AIDS}-related mortality continues to be a challenging issue, all the more so as anti-retroviral treatment programmes alleviate mortality risks. {T}he congruence between these results and other estimates adds plausibility to both approaches. {T}hese data, covering some of the highest mortality observed during the pandemic, will be an important baseline for understanding the future decline of {HIV}/{AIDS}.},
  keywords = {{SIDA} ; {MALADIES} {ASSOCIEES} ; {MORTALITE} ; {TAUX} {DE} {MORTALITE} ; {ENQUETE} ; {SURVEILLANCE} ; {SURVEILLANCE} {SANITAIRE} ; {TUBERCULOSE} ; {ASIE} ; {BANGLADESH} ; {INDE} ; {INDONESIE} ; {VIET} {NAM} ; {AFRIQUE} {SUBSAHARIENNE} ; {AFRIQUE} {DU} {SUD} ; {BURKINA} {FASO} ; {COTE} {D}'{IVOIRE} ; {ETHIOPIE} ; {GAMBIE} ; {GHANA} ; {KENYA} ; {MALAWI} ; {SENEGAL}},
  booktitle = {},
  journal = {{G}lobal {H}ealth {A}ction},
  volume = {7},
  numero = {},
  pages = {art. 23370 [11 ]},
  ISSN = {1654-9880},
  year = {2014},
  DOI = {10.3402/gha.v7.25370},
  URL = {https://www.documentation.ird.fr/hor/fdi:010063238},
}